Human Pathology
Volume 36, Issue 5 , Pages 451-452 , May 2005

Do we need two more mesothelial markers?

References 

  1. Ordóñez NG. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol. 2005;36:1
  2. Kimura N, Kimura I. Podoplanin as a marker for mesothelioma. Pathol Int. 2005;55:83–86
  3. Chu AY, Litzky LA, Pasha TL, Acs G, Zhang PJ. Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol. 2005;18:105–110
  4. Chu AY, Litzky LA, Pasha TL, Zhang PJ. Utility of monoclonal D2-40 in diagnosing malignant mesothelioma. [abstract] Mod Pathol. 2004;17(Suppl. 1):335A
  5. Sienko A, Zander D, Killen D, Singhal N, Barrios R, Haque A, et al. D2-40 is a novel new marker of malignant mesothelioma (MM): tissue microarray study of 45 MM versus 409 lung carcinomas and primary non-mesothelial neoplasms of the pleura and chest wall. [abstract] Mod Pathol. 2005;18(Suppl. 1):318A
  6. Battifora H. The Pleura. In:  Mills SE,  Carter D,  Greenson JK,  Oberman HA,  Reuter VE,  Stoler MH editor. Diagnostic surgical pathology. Philadelphia: Lippincott Williams & Wilkins; 2004;p. 1223–1252
  7. Kaufmann O, Fietze E, Mengs J, Dietel M. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol. 2001;116:823–830

PII: S0046-8177(05)00169-3

doi: 10.1016/j.humpath.2005.04.001

Human Pathology
Volume 36, Issue 5 , Pages 451-452 , May 2005